2017-06-29T08:30:05-05:00 2016-12-31 541149263 YOUNT HYDE & BARBOUR PC PO BOX 2560 WINCHESTER VA 226041760 990 2016-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 20006 KATHRYN GLEASON VICE PRESIDENT 2028272100 2017-06-26 1 OLIVIA A HUTTON CPA P00964688 5406623417 2017-06-14 64.4.100.170 2017-06-26 16:38:31 ED P 7099E3890FFD61678CB8BA14DC834C8DD57F9D5C 7099E3890FFD61678CB8BA14DC834C8DD57F9D5C 2016 2021-01-29 14:40:06Z KATHRYN GLEASON 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 23868892 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) FOCUSES ON RESEARCH AND DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. 22 22 15 0 0 0 0 0 8186800 8292500 360879 220710 0 0 8547679 8513210 0 0 0 0 4396973 4129152 0 0 0 4021351 4707052 8418324 8836204 129355 -322994 19206890 18779988 7042865 6692069 12164025 12087919 TO SPONSOR, PARTICIPATE IN AND PROMOTE THE SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF IMPROVED HEALTH OUTCOMES THROUGH PHARMACEUTICAL INNOVATION. 0 0 THE NATIONAL PHARMACEUTICAL COUNCIL SPONSORS AND CONDUCTS SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF INNOVATION. THE ORGANIZATION'S STRATEGIC FOCUS IS ON EVIDENCE-BASED MEDICINE (EBM) FOR HEALTH CARE DECISION-MAKING TO ENSURE THAT PATIENTS HAVE ACCESS TO HIGH-QUALITY CARE. ALL ACTIVITIES UNDERTAKEN BY THE COUNCIL RELATE TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 17 0 1 15 1 0 0 0 0 1 1 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 DANIEL LEONARD PRESIDENT 40.00 X X 1206874 0 34859 ROBERT DUBOIS VICE PRESIDENT 40.00 X X 641479 0 32409 JEFF STEWART TREASURER 1.00 X 0 0 0 JOSHUA OFMAN VICE CHAIRMAN 1.00 X 0 0 0 GREG KEENAN DIRECTOR 1.00 X 0 0 0 DAVID MILLER DIRECTOR 1.00 X 0 0 0 MICHAEL RYAN DIRECTOR 1.00 X 0 0 0 MARK NAGY DIRECTOR 1.00 X 0 0 0 JAN HANSEN DIRECTOR 1.00 X 0 0 0 GAVIN CORCORAN DIRECTOR 1.00 X 0 0 0 JEFFREY BLOSS DIRECTOR 1.00 X 0 0 0 DON SAWYER DIRECTOR 1.00 X 0 0 0 CHRISTINE MARSH DIRECTOR 1.00 X 0 0 0 RICHARD BAGGER DIRECTOR 1.00 X 0 0 0 JULIE LOCKLEAR DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 STEVEN ROMANO DIRECTOR 1.00 X 0 0 0 ROBERT SPURR DIRECTOR 1.00 X 0 0 0 TRACY MAYNE DIRECTOR 1.00 X 0 0 0 DARRYL SLEEP DIRECTOR 1.00 X 0 0 0 PATRICK MAGRI CHARIMAN 1.00 X 0 0 0 MIKE GLADSTONE DIRECTOR 1.00 X 0 0 0 CHRISTOPHER KAPLAN DIRECTOR 1.00 X 0 0 0 GEORGE KEEFE DIRECTOR 1.00 X 0 0 0 KATHRYN GLEASON SECRETARY 40.00 X X 200302 0 16307 JENNIFER GRAFF VP, CER 40.00 X 229537 0 24881 ANDREA HOFELICH VP, COMMUNICATIONS 40.00 X 202603 0 28577 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEARCH 40.00 X 233463 0 27343 MELISSA BAULKWILL DIRECTOR OF AMINISTRATION 40.00 X 109600 0 26862 MICHAEL CIARAMENTARO VP, RESEARCH 40.00 X 200197 0 22103 3024055 0 213341 8 0 1 0 TUFTS MEDICAL CENTER 800 WASHINGTON ST BOX 453 BOSTON MA 02111 RESEARCH 336190 RTI HEALTH SOLUTIONS PO BOX 14668 RESEARCH TRIANGLE PARK NC 27709 RESEARCH 273152 DISCERN HEALTH 1120 NORTH CHARLES STREET STE 200 BALTIMORE MD 21201 RESEARCH 254022 JONES PUBLIC AFFAIRS 1420K STREET NW STE 1050 WASHINGTON DC 20005 PR AGENCY 244338 HEALTHCORE 123 JUSTISON SUITE 200 WILMINGTON DE 19801 RESEARCH 215206 5 MEMBERSHIP DUES 900099 8187500 8187500 PROGRAM INCOME 900099 105000 105000 8292500 236726 236726 15339666 15321721 33961 17945 -33961 -16016 -16016 8513210 8292500 0 220710 2878635 588327 99702 430066 132422 125663 61458 37105 638460 117641 288964 347117 88669 107931 77711 42792 PROGRAMS, SPECIAL STUDI 2757226 ENTERTAINMENT 8388 SUBSCRIPTIONS & MEMBERS 5865 CONTINUING EDUCATION 2062 8836204 228802 3332721 4018432 621036 218213 260050 694510 371467 347208 323043 14326235 14175138 68000 68000 19206890 18779988 806686 742492 2450000 2275000 3786179 3674577 7042865 6692069 X 12164025 12086834 1085 12164025 12087919 19206890 18779988 -322994 246888 0 X X 0 1 X 1 0 1 1 0 376040 169217 206823 216448 187555 28893 102022 14695 87327 323043 PENSION COST LIABILITY 2184274 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 1263072 DEFERRED LEASE INCENTIVE, NET 227231 3674577 8794059 246888 246888 8547171 -33961 -33961 8513210 8870165 33961 33961 8836204 0 8836204 PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL -33,961. PART XII, LINE 2D - OTHER ADJUSTMENTS: LOSS ON DISPOSAL 33,961. X 1 1 X X X 0 1 0 DANIEL LEONARD PRESIDENT 642834 0 301977 0 262063 0 13250 0 21609 0 1241733 0 0 0 ROBERT DUBOIS VICE PRESIDENT 555064 0 50923 0 35492 0 13250 0 19159 0 673888 0 0 0 KATHRYN GLEASON SECRETARY 177165 0 21630 0 1507 0 9013 0 7294 0 216609 0 0 0 JENNIFER GRAFF VP, CER 202341 0 21622 0 5574 0 10811 0 14070 0 254418 0 0 0 ANDREA HOFELICH VP, COMMUNICATIONS 175516 0 21630 0 5457 0 9013 0 19564 0 231180 0 0 0 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEARCH 205892 0 25947 0 1624 0 10812 0 16531 0 260806 0 0 0 MICHAEL CIARAMENTARO VP, RESEARCH 176929 0 21754 0 1514 0 5476 0 16627 0 222300 0 0 0 PART I, LINE 1A DANIEL LEONARD RECEIVES GROSS-UP PAYMENTS TO THE NONQUAILIFIED RETIREMENT PLAN AVAILABLE TO OFFICERS. THESE PAYMENTS ARE INCLUDED IN THEIR TAXABLE COMPENSATION WHEN PAID. PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN - DANIEL LEONARD - $256,489 FORM 990, PAGE ONE, HEADING J, WEBSITES WWW.RXROI.ORG, WWW.NPCNOW.ORG, WWW.YOURPHARMACYBENEFIT.ORG FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE VICE PRESIDENT OF MEMBERSHIP AND OPERATIONS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE PRESIDENT WHICH ARE REVIEWED AND MAINTAINED BY THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS. THE BOARD OFFICERS REVIEW EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION INCLUDES A REVIEW AND APPROVAL BY THE CHAIRMAN OF BOARD, WHO IS AN INDEPENDENT BOARD MEMBER ELECTED ANNUALLY ON A ROTATING BASIS. COMPARABILITY DATA USED IN THE REVIEW PROCESS IS OBTAINED FROM PUBLIC SOURCES, RECRUITERS, AND OTHER HUMAN RESOURCE PROFESSIONALS. THE AUDIT AND BUDGET COMMITTEE APPROVES TOTAL SALARIES AS APPROVED BY THE CHAIRMAN. THE COMPENSATION DETERMINATION PROCESS APPLIES TO THE MOST RECENT YEAR FOR WHICH THE PROCESS WAS UNDERTAKEN. THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET, WHICH ARE ALSO APPROVED BY THE AUDIT AND BUDGET COMMITTEES. ALL SALARIES WERE REVIEWED AND APPROVED IN 2016. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: PROCESS HAS NOT CHANGED.